Mimedx (MDXG) Liabilities from Discontinued Operations (2022 - 2024)

Mimedx has disclosed Liabilities from Discontinued Operations across 3 years of filings, most recently posting 217000.0 for Q2 2024.

• Liabilities from Discontinued Operations for Q2 2024 came in at 217000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was 217000.0 (changed N/A YoY), and the FY2023 annual result was 1352000.0, down 8.59% from the prior year.
• Liabilities from Discontinued Operations came in at 217000.0 for Q2 2024 at Mimedx, down from 344000.0 in the prior quarter.
• In the past five years, Liabilities from Discontinued Operations ranged from a high of 1479000.0 in Q4 2022 to a low of 217000.0 in Q2 2024.
• The 3-year median for Liabilities from Discontinued Operations is 848000.0 (2023), against an average of 848000.0.
• Peak annual rise in Liabilities from Discontinued Operations reached 8.59% in 2023, while the deepest fall reached 8.59% in 2023.
• Mimedx's Liabilities from Discontinued Operations stood at 1479000.0 in 2022, then retreated by 8.59% to 1352000.0 in 2023, then slumped by 83.95% to 217000.0 in 2024.
• The last three Liabilities from Discontinued Operations figures came in at 217000.0 (Q2 2024), 344000.0 (Q1 2024), and 1352000.0 (Q4 2023), per Business Quant data.